Ben Stokes, KL Rahul Lead $4.5 Million Investment in Dineout Founders’ Medical Travel Startup

Ankit Mehrotra and Sahil Jain, the duo behind restaurant-tech startup Dineout, have raised $4.5 million in a seed round for their new venture, The Medical Travel Company (TMTC). The round was led by Nexus Venture Partners with support from athlete-led VC collective 4CAST (co-founded by Ben Stokes, Jofra Archer, and KL Rahul) and several angel investors.

The Funding Round & Investors:

• The seed round was spearheaded by Nexus Venture Partners.
• Participating investors include Kriscore Capital, and 4CAST, backed by cricketers Ben Stokes, Jofra Archer, and KL Rahul.
• Angel investors in the round include:
  • Sriharsha Majety (Swiggy)
  • Abhishek Goyal (Tracxn)
  • Dr. Ritesh Malik (Innov8)
  • Manish Vij (Smile Group)
  • Arjun Vaidya (V3 Ventures)
  • Also participation from 1947 Rise Fund and Peercheque

What The Medical Travel Company Does:

TMTC is a cross-border medical travel platform offering UK patients access to quality healthcare in India with full oversight and continuity of care.

Key features of its model include:

• UK doctor oversight: Patients retain involvement of UK doctors before, during, and after treatment.
• Accredited care in India: Hospitals meet JCI / NABH accreditation standards.
• Post-surgery insurance: TMTC offers a 12-month insurance policy valid in the UK for patients returning after treatment.
• End-to-end logistics & aftercare: The startup handles rehabilitation, travel, and supportive services as part of a seamless patient journey.

One of the motivations behind this business is the long wait times in the UK healthcare system: currently, 7.7 million people in the UK wait for elective procedures. TMTC aims to offer faster and cost-effective alternatives via its India connection.

Founders & Their Background:

• Ankit Mehrotra and Sahil Jain previously built Dineout, which was acquired by Swiggy in 2022.
• Their experience in consumer tech and scaling operations is expected to help TMTC in managing patient acquisition, operations, and trust.
• As they build TMTC, they emphasize that medical travel is a broken industry, characterised by fragmentation, hidden costs, and poor post-treatment support.

Use of Funds & Expansion Plans:

• The raised capital will be used to enhance digital patient management systems, expand clinical partnerships in India, and scale operations in the UK.
• Over the next 3-4 years, TMTC plans to expand to additional geographies: US, Canada, Australia, and Europe.